165 related articles for article (PubMed ID: 9344896)
1. Hepatic foci in rats after diethylnitrosamine initiation and 2,3,7,8-tetrachlorodibenzo-p-dioxin promotion: evaluation of a quantitative two-cell model and of CYP 1A1/1A2 as a dosimeter.
Conolly RB; Andersen ME
Toxicol Appl Pharmacol; 1997 Oct; 146(2):281-93. PubMed ID: 9344896
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of enzyme-altered liver foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin.
Moolgavkar SH; Luebeck EG; Buchmann A; Bock KW
Toxicol Appl Pharmacol; 1996 May; 138(1):31-42. PubMed ID: 8658510
[TBL] [Abstract][Full Text] [Related]
3. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
Tritscher AM; Goldstein JA; Portier CJ; McCoy Z; Clark GC; Lucier GW
Cancer Res; 1992 Jun; 52(12):3436-42. PubMed ID: 1596902
[TBL] [Abstract][Full Text] [Related]
4. Time- and concentration-dependent induction of CYP1A1 and CYP1A2 in precision-cut rat liver slices incubated in dynamic organ culture in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Drahushuk AT; McGarrigle BP; Slezak BP; Stegeman JJ; Olson JR
Toxicol Appl Pharmacol; 1999 Mar; 155(2):127-38. PubMed ID: 10053167
[TBL] [Abstract][Full Text] [Related]
5. Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8-TCDD.
Portier CJ; Sherman CD; Kohn M; Edler L; Kopp-Schneider A; Maronpot RM; Lucier G
Toxicol Appl Pharmacol; 1996 May; 138(1):20-30. PubMed ID: 8658509
[TBL] [Abstract][Full Text] [Related]
6. Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats.
Tritscher AM; Clark GC; Sewall C; Sills RC; Maronpot R; Lucier GW
Carcinogenesis; 1995 Nov; 16(11):2807-11. PubMed ID: 7586202
[TBL] [Abstract][Full Text] [Related]
7. Hepatocarcinogenesis in female Sprague-Dawley rats following discontinuous treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Tritscher AM; Sills RC; Lucier GW; Portier CJ
Toxicol Sci; 2000 Apr; 54(2):330-7. PubMed ID: 10774815
[TBL] [Abstract][Full Text] [Related]
8. Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multicompartment geometric model of hepatic zonation.
Andersen ME; Birnbaum LS; Barton HA; Eklund CR
Toxicol Appl Pharmacol; 1997 May; 144(1):145-55. PubMed ID: 9169078
[TBL] [Abstract][Full Text] [Related]
9. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on initiation and promotion of GST-P-positive foci in rat liver: A quantitative analysis of experimental data using a stochastic model.
Luebeck EG; Buchmann A; Stinchcombe S; Moolgavkar SH; Schwarz M
Toxicol Appl Pharmacol; 2000 Aug; 167(1):63-73. PubMed ID: 10936080
[TBL] [Abstract][Full Text] [Related]
10. Promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin and 17beta-estradiol in male Sprague-Dawley rats.
Wyde ME; Cambre T; Lebetkin M; Eldridge SR; Walker NJ
Toxicol Sci; 2002 Aug; 68(2):295-303. PubMed ID: 12151625
[TBL] [Abstract][Full Text] [Related]
11. Promotion of N-nitrosodiethylamine-initiated hepatocellular tumors and hepatoblastomas by 2,3,7,8-tetrachlorodibenzo-p-dioxin or Aroclor 1254 in C57BL/6, DBA/2, and B6D2F1 mice.
Beebe LE; Fornwald LW; Diwan BA; Anver MR; Anderson LM
Cancer Res; 1995 Nov; 55(21):4875-80. PubMed ID: 7585523
[TBL] [Abstract][Full Text] [Related]
12. Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction.
Drahushuk AT; McGarrigle BP; Tai HL; Kitareewan S; Goldstein JA; Olson JR
Toxicol Appl Pharmacol; 1996 Oct; 140(2):393-403. PubMed ID: 8887457
[TBL] [Abstract][Full Text] [Related]
13. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis.
Lucier GW; Tritscher A; Goldsworthy T; Foley J; Clark G; Goldstein J; Maronpot R
Cancer Res; 1991 Mar; 51(5):1391-7. PubMed ID: 1671757
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats.
Teeguarden JG; Dragan YP; Singh J; Vaughan J; Xu YH; Goldsworthy T; Pitot HC
Toxicol Sci; 1999 Oct; 51(2):211-23. PubMed ID: 10543023
[TBL] [Abstract][Full Text] [Related]
15. Differences in kinetics of induction and reversibility of TCDD-induced changes in cell proliferation and CYP1A1 expression in female Sprague-Dawley rat liver.
Walker NJ; Miller BD; Kohn MC; Lucier GW; Tritscher AM
Carcinogenesis; 1998 Aug; 19(8):1427-35. PubMed ID: 9744539
[TBL] [Abstract][Full Text] [Related]
16. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
[TBL] [Abstract][Full Text] [Related]
18. Tumor promoters as inhibitors of apoptosis in rat hepatocytes.
Schrenk D; Schmitz HJ; Bohnenberger S; Wagner B; Wörner W
Toxicol Lett; 2004 Apr; 149(1-3):43-50. PubMed ID: 15093247
[TBL] [Abstract][Full Text] [Related]
19. A pharmacodynamic analysis of TCDD-induced cytochrome P450 gene expression in multiple tissues: dose- and time-dependent effects.
Santostefano MJ; Wang X; Richardson VM; Ross DG; DeVito MJ; Birnbaum LS
Toxicol Appl Pharmacol; 1998 Aug; 151(2):294-310. PubMed ID: 9707506
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of avian CYP1A4 and CYP1A5 by 2,3,7, 8-tetrachlorodibenzo-p-dioxin: differences in gene expression and regulation compared to mammalian CYP1A1 and CYP1A2.
Mahajan SS; Rifkind AB
Toxicol Appl Pharmacol; 1999 Feb; 155(1):96-106. PubMed ID: 10036222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
